| Muscle . | Condition . | Wild type . | MasR−/− . | ||
|---|---|---|---|---|---|
| Time to peak (ms) . | Half-relaxation time (ms) . | Time to peak (ms) . | Half-relaxation time (ms) . | ||
| EDL | Innervated | 7.2 ± 1.1 | 5.8 ± 0.3 | 8.2 ± 0.8 | 10.2 ± 1.2 |
| EDL | Denervated | 14.8 ± 1.4a | 9.4 ± 1.1 | 13.4 ± 0.8a | 17.0 ± 1.5a,b |
| EDL | Denervated Ang 1–7 | 13.0 ± 1.1a | 11.9 ± 0.7a | 17.3 ± 4.2a,b | 20.5 ± 5.3a,b |
| Soleus | Innervated | 15.7 ± 0. 6 | 10.3 ± 1.1 | 13.3 ± 0.7 | 16.6 ± 2.24 |
| Soleus | Denervated | 33.7 ± 1.0a | 38.5 ± 4.9a | 28.9 ± 1.7a | 43.9 ± 4.5a |
| Soleus | Denervated Ang 1–7 | 34.7 ± 1.1a | 37.2 ± 2.7a | 25.3 ± 3.5a,b | 35.6 ± 9.1a |
| Muscle . | Condition . | Wild type . | MasR−/− . | ||
|---|---|---|---|---|---|
| Time to peak (ms) . | Half-relaxation time (ms) . | Time to peak (ms) . | Half-relaxation time (ms) . | ||
| EDL | Innervated | 7.2 ± 1.1 | 5.8 ± 0.3 | 8.2 ± 0.8 | 10.2 ± 1.2 |
| EDL | Denervated | 14.8 ± 1.4a | 9.4 ± 1.1 | 13.4 ± 0.8a | 17.0 ± 1.5a,b |
| EDL | Denervated Ang 1–7 | 13.0 ± 1.1a | 11.9 ± 0.7a | 17.3 ± 4.2a,b | 20.5 ± 5.3a,b |
| Soleus | Innervated | 15.7 ± 0. 6 | 10.3 ± 1.1 | 13.3 ± 0.7 | 16.6 ± 2.24 |
| Soleus | Denervated | 33.7 ± 1.0a | 38.5 ± 4.9a | 28.9 ± 1.7a | 43.9 ± 4.5a |
| Soleus | Denervated Ang 1–7 | 34.7 ± 1.1a | 37.2 ± 2.7a | 25.3 ± 3.5a,b | 35.6 ± 9.1a |
Ang 1–7 was delivered using an osmotic pump at a rate of 15 mg/kg/d. Data are presented as mean ± SE of five or six muscles.
Mean value is significantly different from that of innervated muscles (ANOVA and LSD, P < 0.05).
Mean value is significantly different from CD-1 muscles (ANOVA and LSD, P < 0.05).